Source: Pharmabiz

Roche: US FDA grants breakthrough device designation to Roche's companion diagnostic, VENTANA TROP2 (EPR20043) RxDx Device for nonsmall cell lung cancer

Roche announced that the US Food and Drug Administration (FDA) granted Breakthrough Device Designation for the VENTANA TROP2 (EPR20043) RxDx Device.

Read full article »

Roche's Competitors | Roche's News | Roche's Financials

Followers on Owler

33,614

Annual Revenue

$50-100B

Employees

100K-9.9M

CEO

Thomas Schinecker

CEO Approval Rating

72/100

Roche is a Switzerland-based biotechnology company that discovers, develops, and provides diagnostic and pharmaceutical products and services for the healthcare sector.